Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANTHARIDIN vs CAPMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANTHARIDIN vs CAPMATINIB: Safety Overview

Metric CANTHARIDIN CAPMATINIB
Total FAERS Reports 114 2,301
Deaths Reported 0 583
Death Rate N/A 25.3%
Hospitalizations 3 388
Average Patient Age 17.6 yrs 71.9 yrs
% Female Patients 53.3% 53.9%
FDA Approval Date Jul 21, 2023 May 6, 2020
Manufacturer Verrica Pharmaceuticals Inc. Novartis Pharmaceuticals Corporation
Route TOPICAL ORAL
Marketing Status Prescription Prescription